KPIs & Operating Metrics(New)

Balance Sheet

Cash Flow Statement

Acquisitions Amortization of Goodwill Amortization of Goodwill Asset Writedowns and Impairment Asset Writedowns and Impairment Capital Expenditures Capital Expenditures Cash from Discontinued Operations Cash from Discontinued Operations Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Accured Expenses Change in Accured Expenses Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Change in Intangibles Change in Intangibles Change in Inventory Change in Inventory Change in Receivables Change in Receivables Change in Taxes Change in Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Divestments Dividends Paid - Common Dividends Paid - Common Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Gains from Sales and Divestitures Gains from Sales and Divestitures Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Sales of Property, Plant and Equipment Sales of Property, Plant and Equipment Share-based Compensation Share-based Compensation Shares Issued Shares Repurchased Short-Term Debt issuances

Daily Values

Growth Metrics

Zimmer Biomet Holdings (ZBH) Short-Term Debt repayments (2018 - 2023)

Zimmer Biomet Holdings has reported Short-Term Debt repayments over the past 2 years, most recently at $305.0 million for Q4 2023.

For Q4 2023, Short-Term Debt repayments changed N/A year-over-year to $305.0 million; the TTM value through Dec 2024 reached $165.0 million, down 49.23%, while the annual FY2024 figure was $50.0 million, 84.62% down from the prior year.
Short-Term Debt repayments for Q4 2023 was $305.0 million at Zimmer Biomet Holdings, up from -$405.0 million in the prior quarter.
Over five years, Short-Term Debt repayments peaked at $305.0 million in Q4 2023 and troughed at -$405.0 million in Q3 2023.